DRUGBright Minds Biosciences Inc.
$54.28-1.7% 1Y
$54.28
$48.0952 weeks$95.99
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−28% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 9, 2026
In a downtrend, below its 50- and 200-day averages. Price is −28% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DRUG is trading
Bright Minds Biosciences Inc. is −1.7% over the past year while the S&P 500 is +18%: 20 points behind the market.
−1.7%
1-year return · S&P 500 +18%
- vs 200-day average
- −28%
vs 200-day average · a clear downtrend
- RSI (14)
- 38
RSI (14) · neutral
- Below its 52-week high
- 43%
Below its 52-week high
Details›
- Last close2026-10-09
- $54.28
- 1 monthS&P 500 +2.7%
- −17%
- 1 yearS&P 500 +18%
- −1.7%
- 5 yearsS&P 500 +88%
- +51%
- vs 50-day average$66.99
- −19%
- 52-week high
- $95.99
- 52-week low
- $48.09
- Annualised volatility
- 1032%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$9.8M
| Year | Return |
|---|---|
| 2026 (year to date) | −30% |
| 2025 | +117% |
| 2024 | +2419% |
| 2023 | −61% |
| 2022 | −77% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | +3.8% |
| Feb | 5 | 2 of 5 | −6.6% |
| Mar | 5 | 0 of 5 | −20% |
| Apr | 6 | 2 of 6 | −4.2% |
| May | 6 | 4 of 6 | +5.1% |
| Jun | 6 | 1 of 6 | −11% |
| Jul | 6 | 6 of 6 | +19% |
| Aug | 6 | 3 of 6 | +10% |
| Sep | 6 | 3 of 6 | +1.4% |
| Oct | 6 | 2 of 6 | +644% |
| Nov | 5 | 2 of 5 | −2.0% |
| Dec | 5 | 2 of 5 | −11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.